Form Bio News

All the latest Form happenings. Want to stay in the loop? Subscribe Now

Sort
June 10, 2026
June 16, 2026
thumbnail

Leaders at the Frontier: Conversations From SynBioBeta 2026

Source:
IN VIVO

In Vivo spoke with founders, investors, and platform builders at the intersection of synbio and biopharma. Their conversations reveal a field maturing fast, but with leaders who know exactly where the hype ends and the hard work begins.

May 11, 2026
June 16, 2026
thumbnail

Announcing FormManufacturing, an End-to-End Platform for AI-Driven Design and Manufacturing of Genetic Medicines

Source:
ACCESS NEWSWIRE

FormManufacturing integrates AI-driven design optimization with deep genomic characterization to address the critical challenge of ensuring that the therapy designed is the therapy manufactured.

October 30, 2025
November 3, 2025
thumbnail

Form Bio and Weill Cornell Medicine Announce Strategic Collaboration to Advance Gene Editing Therapy for Alzheimer’s Disease

Source:
Access Newswire

AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer’s disease.

October 6, 2025
October 29, 2025
thumbnail

Form Bio and Cure Rare Disease Partner to Accelerate Genetic Medicine Development, Advancing CRD's DMD Program

Source:
Access Newswire

Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular diseases

August 18, 2025
October 29, 2025
thumbnail

Michelle Chen Named CEO of Gene Therapy Play Form Bio

Source:
BioCentury

She succeeds co-founders Andrew Busey, CEO, and President and COO Kent Wakeford, who have led the Texas-based biotech since its 2022 spinout from Colossal Biosciences.